Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

A Case of Doxycycline-induced Melanin in the Gingiva Tissue: Case Report

Author(s): Gustavo Henrique Apolinário Vieira, Aurigena Antunes de Araújo*, Rebeca Sá Leitão de Freitas, Lélia Batista de Souza, Ciro Dantas Soares, Lilian Karine Cardoso Guimarães de Carvalho, Samuel Batista Borges, Bruno Cesár de Vasconcelos Gurgel, Euler Maciel Dantas and Delane Maria Rêgo

Volume 18, Issue 3, 2023

Published on: 07 October, 2022

Page: [413 - 423] Pages: 11

DOI: 10.2174/1574886317666220514161729

Price: $65

Abstract

Background: Gingival pigmentation is a discoloration of the gingiva due to a variety of lesions and conditions associated with several endogenous and exogenous etiologic features.

Objective: The purpose of this study is to describe a report of gingival pigmentation in a patient who used doxycycline.

Case Report: A 21-year-old Caucasian female was under dermatological treatment and antibiotic therapy with doxycycline 100 mg (one time a day) for 90 days. She presented brown pigmentation at the gingival margin on the facial surfaces of the upper and lower anterior incisors and premolars. The patient was evaluated by immunohistochemical (S-100, Melan-A, and HMB-45) and histopathologic analyses, and clinical history. Blood levels of malondialdehyde (MDA), glutathione (GSH), and superoxide dismutase (SOD) were analyzed by UV/Vis spectroscopy. The adrenaline, noradrenaline, and dopamine in blood were analyzed by high-performance liquid chromatography (HPLC); dehidroepiandrosterone (DHEA) in serum by radioimmunoassay; and luteinizing hormone (LH) and 25-Hydroxyvitamin D by chemiluminescence. Hematoxylin-eosin stained sections revealed keratinocytes with pigment compatible with melanin. The Fontana-Masson staining was positive in melanophages and in some basal keratinocytes. S-100, Melan A and HMB-45 were confirmed as positive markers of melanocytic differentiation in gingival tissue. We observed a significant increase in malondialdehyde (p˂0.05) and a decrease in superoxide dismutase levels (p˂0.05). The dopamine value was found to be 15 pg/ml (reference value ≤ 10 pg/ml).

Conclusion: The use of doxycycline is associated with an increase in oxidative stress and of dopamine with melanin pigments in the gingival tissue. This case report showed a cause-effect relationship between exposure to doxycycline and pigmentation of the marginal gingiva.

Keywords: Doxycycline, periodontal tissue, melanin, dopamine, oxidative stress, DOPA.

« Previous
[1]
Kauzman A, Pavone M, Blanas N, Bradley G. Pigmented lesions of the oral cavity: Review, differential diagnosis, and case presentations. J Can Dent Assoc 2004; 70(10): 682-3.
[PMID: 15530266]
[2]
Lerner AB, Fitzpatrick TB. Biochemistry of melanin formation. Physiol Rev 1950; 30(1): 91-126.
[http://dx.doi.org/10.1152/physrev.1950.30.1.91] [PMID: 15403662]
[3]
Ship JA, Greenberg MS, Michael G, Eds. Burket’s oral medicine: Pigmented lesions of the oral mucosa. (10th ed.), Hamilton, Ontario: BC Decker Inc 2003.
[4]
Fiscus V, Hankinson A, Alweis R. Minocycline-induced hyperpigmentation. J Community Hosp Intern Med Perspect 2014; 4(3): 24063.
[http://dx.doi.org/10.3402/jchimp.v4.24063] [PMID: 25147636]
[5]
Chopra I, Roberts M. Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001; 65(2): 232-60.
[http://dx.doi.org/10.1128/MMBR.65.2.232-260.2001] [PMID: 11381101]
[6]
Bonnetblanc JM. Doxycycline. Ann Dermatol Venereol 2002; 129(6-7): 874-82.
[PMID: 12218915]
[7]
Cunha BA, Sibley CM, Ristuccia AM. Doxycycline. Ther Drug Monit 1982; 4(2): 115-35.
[http://dx.doi.org/10.1097/00007691-198206000-00001] [PMID: 7048645]
[8]
Cross R, Ling C, Day NP, McGready R, Paris DH. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf 2016; 15(3): 367-82.
[http://dx.doi.org/10.1517/14740338.2016.1133584] [PMID: 26680308]
[9]
Griffin MO, Fricovsky E, Ceballos G, Villarreal F. Tetracyclines: A pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 2010; 299(3): C539-48.
[http://dx.doi.org/10.1152/ajpcell.00047.2010] [PMID: 20592239]
[10]
Bostanci N, Akgül B, Tsakanika V, Allaker RP, Hughes FJ, McKay IJ. Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans. Cytokine 2011; 56(3): 656-61.
[http://dx.doi.org/10.1016/j.cyto.2011.08.039] [PMID: 21962932]
[11]
Golub LM, Ryan ME, Williams RC. Modulation of the host response in the treatment of periodontitis. Dent Today 1998; 17(10): 102-6.
[12]
Preshaw PM. Host response modulation in periodontics. Periodontol 2000 2008; 48: 92-110.
[http://dx.doi.org/10.1111/j.1600-0757.2008.00252.x] [PMID: 18715360]
[13]
Salman RA, Salman DG, Glickman RS, Super S, Salman L. Minocycline induced pigmentation of the oral cavity. J Oral Med 1985; 40(3): 154-7.
[PMID: 3861819]
[14]
Sánchez AR, Rogers RS III, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol 2004; 43(10): 709-15.
[http://dx.doi.org/10.1111/j.1365-4632.2004.02108.x] [PMID: 15485524]
[15]
Siller GM, Tod MA, Savage NW. Minocycline-induced oral pigmentation. J Am Acad Dermatol 1994; 30(2 Pt 2): 350-4.
[http://dx.doi.org/10.1016/S0190-9622(94)70038-9] [PMID: 8294596]
[16]
LaPorta VN, Nikitakis NG, Sindler AJ, Reynolds MA. Minocycline-associated intra-oral soft-tissue pigmentation: Clinicopathologic correlations and review. J Clin Periodontol 2005; 32(2): 119-22.
[http://dx.doi.org/10.1111/j.1600-051X.2005.00646.x] [PMID: 15691339]
[17]
Westbury LW, Najera A. Minocycline-induced intraoral pharmacogenic pigmentation: Case reports and review of the literature. J Periodontol 1997; 68(1): 84-91.
[http://dx.doi.org/10.1902/jop.1997.68.1.84] [PMID: 9029456]
[18]
Treister NS, Magalnick D, Woo SB. Oral mucosal pigmentation secondary to minocycline therapy: Report of two cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97(6): 718-25.
[http://dx.doi.org/10.1016/j.tripleo.2003.11.006] [PMID: 15184854]
[19]
International drug monitoring: The role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser 1972; 498: 1-25.
[PMID: 4625548]
[20]
Shukla AK, Jhaj R, Misra S, Ahmed SN, Nanda M, Chaudhary D. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions. J Family Med Prim Care 2021; 10(9): 3303-8.
[http://dx.doi.org/10.4103/jfmpc.jfmpc_831_21] [PMID: 34760748]
[21]
Ampadu HH, Hoekman J, de Bruin ML, et al. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. Drug Saf 2016; 39(4): 335-45.
[http://dx.doi.org/10.1007/s40264-015-0387-4] [PMID: 26754924]
[22]
Ministério da Saúde do Brasil. Portaria nº 696. 2001. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2001/prt06 96_07_05_2001.html
[23]
Siddique YH, Ara G, Afzal M. Estimation of lipid peroxidation induced by hydrogen peroxide in cultured human lymphocytes. Dose Response 2012; 10(1): 1-10.
[http://dx.doi.org/10.2203/dose-response.10-002.Siddique] [PMID: 22423225]
[24]
Ullah H, Khan MF, Hashmat F. Determination of glutathione concentration after its interaction with cadmium nitrate tetrahydrate by using Ellman’s modified method. Gomal Univ J Res 2011; 27: 2.
[25]
Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971; 44(1): 276-87.
[http://dx.doi.org/10.1016/0003-2697(71)90370-8] [PMID: 4943714]
[26]
The use of the WHO-UMC system for standardised case causality assessment. Available from: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf [Acessed 10 March 2022]. [Acessed 10 March 2022]
[27]
Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol 2001; 2(4): 253-62.
[http://dx.doi.org/10.2165/00128071-200102040-00006] [PMID: 11705252]
[28]
Rok J, Rzepka Z, Kowalska J, Banach K, Beberok A. Wrześniok D. Molecular and Biochemical Basis of Minocycline-Induced Hyperpigmentation-The Study on Normal Human Melanocytes Exposed to UVA and UVB Radiation. Int J Mol Sci 2021; 22(7): 3755.
[http://dx.doi.org/10.3390/ijms22073755] [PMID: 33916535]
[29]
Hearing VJ. Determination of melanin synthetic pathways. J Invest Dermatol 2011; 131(E1): E8-E11.
[http://dx.doi.org/10.1038/skinbio.2011.4] [PMID: 22094404]
[30]
Hasegawa T. Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson’s disease. Int J Mol Sci 2010; 11(3): 1082-9.
[http://dx.doi.org/10.3390/ijms11031082] [PMID: 20480001]
[31]
Hasegawa T, Matsuzaki M, Takeda A, et al. Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase. J Neurochem 2003; 87(2): 470-5.
[http://dx.doi.org/10.1046/j.1471-4159.2003.02008.x] [PMID: 14511124]
[32]
Cale AE, Freedman PD, Lumerman H. Pigmentation of the jawbones and teeth secondary to minocycline hydrochloride therapy. J Periodontol 1988; 59(2): 112-4.
[http://dx.doi.org/10.1902/jop.1988.59.2.112] [PMID: 3162266]
[33]
Kowalska J, Rok J, Rzepka Z. Wrześniok D, Beauchamp C, Fridovich I. Drug-induced photosensitivity-from light and chemistry to biological reactions and clinical symptoms. Pharmaceuticals 2021; 14(8): 723.
[http://dx.doi.org/10.3390/ph14080723] [PMID: 34451820]
[34]
Lankerani L, Baron ED. Photosensitivity to exogenous agents. J Cutan Med Surg 2004; 8(6): 424-31.
[http://dx.doi.org/10.1177/120347540400800604] [PMID: 15988550]
[35]
De Mazière AM, Muehlethaler K, van Donselaar E, et al. The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins. Traffic 2002; 3(9): 678-93.
[http://dx.doi.org/10.1034/j.1600-0854.2002.30909.x] [PMID: 12191019]
[36]
Hossain MR, Ansary TM, Komine M, Ohtsuki M. Diversified stimuli-induced inflammatory pathways cause skin pigmentation. Int J Mol Sci 2021; 22(8): 3970.
[http://dx.doi.org/10.3390/ijms22083970] [PMID: 33921371]
[37]
Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira WD, Hearing VJ. MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes. J Biol Chem 2005; 280(14): 14006-16.
[http://dx.doi.org/10.1074/jbc.M413692200] [PMID: 15695812]
[38]
Busam KJ, Jungbluth AA. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 1999; 6(1): 12-8.
[http://dx.doi.org/10.1097/00125480-199901000-00002] [PMID: 10197235]
[39]
Kikuchi A, Shimizu H, Nishikawa T. Expression and ultrastructural localization of HMB-45 antigen. Br J Dermatol 1996; 135(3): 400-5.
[http://dx.doi.org/10.1046/j.1365-2133.1996.d01-1012.x] [PMID: 8949433]
[40]
Edwards SL, Blessing K. Problematic pigmented lesions: Approach to diagnosis. J Clin Pathol 2000; 53(6): 409-18.
[http://dx.doi.org/10.1136/jcp.53.6.409] [PMID: 10911797]

Rights & Permissions Print Cite
Article Metrics
37
2
© 2024 Bentham Science Publishers | Privacy Policy